Microneedle biosensors for real-time, minimally invasive drug monitoring of phenoxymethylpenicillin: a first-in-human evaluation in healthy volunteers

The Lancet Digital Health - Tập 1 - Trang e335-e343 - 2019
Timothy M Rawson1,2,3, Sally A N Gowers2, David M E Freeman2, Richard C Wilson1,3, Sanjiv Sharma4, Mark Gilchrist3, Alasdair MacGowan5, Andrew Lovering5, Mark Bayliss5, Mathew Kyriakides5, Pantelis Georgiou6, Anthony E G Cass7, Danny O'Hare2, Alison H Holmes1,3
1National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK
2Department of Bioengineering, Imperial College London, London, UK
3Imperial College Healthcare National Health Service Trust, Hammersmith Hospital, London, UK
4College of Engineering, Swansea University, Swansea, UK
5Department of Infection Sciences, North Bristol National Health Service Trust, Southmead Hospital, Westbury-on-Trym, Bristol, UK
6Department of Electrical and Electronic Engineering, Imperial College London, London, UK
7Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London, UK

Tài liệu tham khảo

Roberts, 2016, Continuous versus intermittent β-lactam infusion in severe sepsis. A meta-analysis of individual patient data from randomized trials, Am J Respir Crit Care Med, 194, 681, 10.1164/rccm.201601-0024OC Holmes, 2016, Understanding the mechanisms and drivers of antimicrobial resistance, Lancet, 387, 176, 10.1016/S0140-6736(15)00473-0 Rawson, 2018, Delivering precision antimicrobial therapy through closed-loop control systems, J Antimicrob Chemother, 73, 835, 10.1093/jac/dkx458 Roberts, 2014, Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions, Lancet Infect Dis, 14, 498, 10.1016/S1473-3099(14)70036-2 Sime, 2012, Does beta-lactam pharmacokinetic variability in critically ill patients justify therapeutic drug monitoring? A systematic review, Ann Intensive Care, 2, 35, 10.1186/2110-5820-2-35 Clarke, 2016 Henry, 1998, Microfabricated microneedles: a novel approach to transdermal drug delivery, J Pharm Sci, 87, 922, 10.1021/js980042+ Babity, 2018, Advances in the design of transdermal microneedles for diagnostic and monitoring applications, Small, 14, 10.1002/smll.201803186 Hosu, 2019, Minireview: smart tattoo, microneedle, point-of-care, and phone-based biosensors for medical screening, diagnosis, and monitoring, Anal Lett, 52, 78, 10.1080/00032719.2017.1391826 Sharma, 2017, Rapid, low cost prototyping of transdermal devices for personal healthcare monitoring, Sens Bio-Sensing Res, 13, 104, 10.1016/j.sbsr.2016.10.004 El-Laboudi, 2013, Use of microneedle array devices for continuous glucose monitoring: a review, Diabetes Technol Ther, 15, 101, 10.1089/dia.2012.0188 Moniz, 2012, Minimally invasive enzyme microprobes: an alternative approach for continuous glucose monitoring, J Diabetes Sci Technol, 6, 479, 10.1177/193229681200600239 Trzebinski, 2012, Microfluidic device to investigate factors affecting performance in biosensors designed for transdermal applications, Lab Chip, 12, 348, 10.1039/C1LC20885C Gowers, 2019, Development of a minimally-invasive microneedle-based sensor for continuous monitoring of β-lactam antibiotic concentrations in vivo, ACS Sensors, 4, 1072, 10.1021/acssensors.9b00288 Rawson, 2017, Towards a minimally invasive device for beta-lactam monitoring in humans, Electrochem Commun, 82, 1, 10.1016/j.elecom.2017.07.011 Zafeiropoulos, 2018, Performance ANd ACcuracy in Electrical BioActivity Recordings (PANACEA): a high-performance, wireless, multi-instrument for potentiometric and amperometric recording of biosignals, Measurement, 129, 128, 10.1016/j.measurement.2018.05.115 Brunner, 2006, Microdialysis versus other techniques for the clinical assessment of in vivo tissue drug distribution, AAPS J, 8, E263, 10.1007/BF02854896 Shippenberg, 2001, Overview of microdialysis, Curr Protoc Neurosci de la Peña, 2000, Microdialysis in peripheral tissues, Adv Drug Deliv Rev, 45, 189, 10.1016/S0169-409X(00)00106-X 1997 Neely, 2012, Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R, Ther Drug Monit, 34, 467, 10.1097/FTD.0b013e31825c4ba6 Cass, 2017, Microneedle enzyme sensor arrays for continuous in vivo monitoring, Methods Enzymol, 589, 413, 10.1016/bs.mie.2017.02.002 Yan, 2010, Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery, Int J Pharm, 391, 7, 10.1016/j.ijpharm.2010.02.007 Sharma, 2016, Evaluation of a minimally invasive glucose biosensor for continuous tissue monitoring, Anal Bioanal Chem, 408, 8427, 10.1007/s00216-016-9961-6 Nix, 1991, Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response, Antimicrob Agents Chemother, 35, 1953, 10.1128/AAC.35.10.1953 Rowe, 2010, Reagentless measurement of aminoglycoside antibiotics in blood serum via an electrochemical, ribonucleic acid aptamer-based biosensor, Anal Chem, 82, 7090, 10.1021/ac101491d Ferguson, 2013, Real-time, aptamer-based tracking of circulating therapeutic agents in living animals, Sci Transl Med, 5, 10.1126/scitranslmed.3007095 Herrero, 2018, Closed-loop control for precision antimicrobial delivery: an in silico proof-of-concept, IEEE Trans Biomed Eng, 65, 2231, 10.1109/TBME.2017.2787423